Spero Therapeutics (SPRO) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.55
-0.38
-0.2
-0.03

Details

Expected EPS
-0.38
Actual EPS
-0.03
Surprise EPS
0.35
Surprise Percent
+92.11%

Description

Spero Therapeutics (SPRO) has reported earnings of -0.03 per share for Q3 2025.

0 Comments

Share your thoughts